We are live on ! Find out more
Alyeska Investment Group

Alyeska Investment Group Portfolio holdings

AUM $35.4B
1-Year Est. Return 33.54%
This Fund
S&P 500
This Quarter Est. Return
+9.66%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.32%
AUM
$26.6B
AUM Growth
+$7.03B
Cap. Flow
+$6.78B
Cap. Flow %
25.47%
Top 10 Hldgs %
27.09%
Holding
691
New
182
Increased
156
Reduced
161
Closed
155

Top Buys

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$3.51B
2
META icon
Meta Platforms (Facebook)
META
+$681M
3
BA icon
Boeing
BA
+$467M
4
CSCO icon
Cisco
CSCO
+$399M
5
VZ icon
Verizon
VZ
+$367M

Sector Composition

Rank Sector Weight
1 Technology 19.13%
2 Consumer Discretionary 13.33%
3 Industrials 12.74%
4 Healthcare 10.35%
5 Communication Services 7.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NRG icon
426
NRG Energy
NRG
$25B
$3.57M 0.01%
39,611
+6,484
+20% +$601K
FCFS icon
427
FirstCash
FCFS
$9.05B
$3.55M 0.01%
34,249
-269,799
-89% -$29.1M
AROC icon
428
Archrock
AROC
$5.81B
$3.42M 0.01%
137,500
GFL icon
429
GFL Environmental
GFL
$14.9B
$3.34M 0.01%
75,000
-175,000
-70% -$7.62M
NKTX icon
430
Nkarta
NKTX
$176M
$3.32M 0.01%
1,334,696
+250,000
+23% +$772K
BFS
431
Saul Centers
BFS
$839M
$3.31M 0.01%
85,404
-1,821
-2% -$73K
QXO
432
QXO Inc
QXO
$16.6B
$3.24M 0.01%
203,491
-1,357,140
-87% -$21.4M
CBLL
433
CeriBell Inc
CBLL
$732M
$3.23M 0.01%
+125,000
New +$3.41M
MBX
434
MBX Biosciences
MBX
$3.19B
$3.22M 0.01%
174,700
-50,300
-22% -$1.07M
FFIC
435
DELISTED
Flushing Financial
FFIC
$3.16M 0.01%
+221,370
New +$3.53M
SEE
436
DELISTED
Sealed Air
SEE
$3.12M 0.01%
+92,305
New +$3.29M
AMLX icon
437
Amylyx Pharmaceuticals
AMLX
$2.53B
$3.11M 0.01%
823,420
-1,200,000
-59% -$5.65M
GDS icon
438
GDS Holdings
GDS
$6.29B
$3.07M 0.01%
+129,178
New +$2.73M
AVR
439
Anteris Technologies
AVR
$872M
$3.07M 0.01%
+550,000
New +$3.08M
TBBB icon
440
BBB Foods
TBBB
$4.9B
$3.05M 0.01%
107,739
+1,655
+2% +$51.6K
SRPT icon
441
Sarepta Therapeutics
SRPT
$1.81B
$3.04M 0.01%
24,997
-210,243
-89% -$25.8M
NFE icon
442
New Fortress Energy
NFE
$97.8M
$3.02M 0.01%
+200,000
New +$2.07M
NI icon
443
NiSource
NI
$20B
$2.96M 0.01%
+80,394
New +$2.89M
NAMS icon
444
NewAmsterdam Pharma
NAMS
$3.34B
$2.95M 0.01%
114,707
-193,451
-63% -$4.11M
FLNC icon
445
Fluence Energy
FLNC
$2.34B
$2.8M 0.01%
+176,367
New +$3.45M
RITM icon
446
Rithm Capital
RITM
$5.65B
$2.71M 0.01%
250,000
PIII icon
447
P3 Health Partners
PIII
$42.7M
$2.68M 0.01%
238,119
-75,835
-24% -$1.12M
EYPT icon
448
EyePoint Inc
EYPT
$1.13B
$2.62M 0.01%
351,348
+100,000
+40% +$931K
XAIR icon
449
Beyond Air
XAIR
$3.75M
$2.56M 0.01%
+17,855
New +$3.2M
ELUT icon
450
Elutia
ELUT
$36M
$2.41M 0.01%
643,445

Similar funds

Alyeska Investment Group's Q4 2024 Portfolio in Review

As of Q4 2024, Alyeska Investment Group held 691 positions worth $26.6B, up 36% from $19.6B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Alyeska Investment Group deployed $6.78B of net new capital in Q4 2024, opening 182 new positions and adding to 156 existing holdings. Its largest new stake was iShares Core S&P 500 ETF: 5,926,710 shares worth $3.49B.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 24% a quarter earlier, followed by Consumer Discretionary and Industrials.

On the sell side, the largest reduction was United Airlines, an estimated $278M trimmed.

  • Alyeska Investment Group's largest Q4 2024 buy was iShares Core S&P 500 ETF: 5,926,710 shares worth $3.49B.
  • Alyeska Investment Group added most to Meta Platforms (Facebook) in Q4 2024, an estimated $681M increase.
  • Alyeska Investment Group's biggest Q4 2024 reduction was United Airlines, cutting an estimated $278M.
  • Alyeska Investment Group fully exited Home Depot in Q4 2024, selling an estimated $241M.
  • Alyeska Investment Group's ten largest holdings make up 27% of its $26.6B portfolio in Q4 2024.
  • Alyeska Investment Group opened 182 new positions and closed 155 in Q4 2024.
  • Alyeska Investment Group's portfolio value rose 36% quarter-over-quarter to $26.6B.

Based on Alyeska Investment Group's 13F filing for Q4 2024, filed 14 Feb 2025.